Search results for "Lee"

showing 10 items of 1847 documents

Tissue oxygenation in brain, muscle and fat in a rat model of sleep apnea: differential effect of obstructive apneas and intermittent hypoxia.

2011

Study Objectives: To test the hypotheses that the dynamic changes in brain oxygen partial pressure (PtO 2) in response to obstructive apneas or to intermittent hypoxia differ from those in other organs and that the changes in brain PtO 2 in response to obstructive apneas is a source of oxidative stress. Design: Prospective controlled animal study. Setting: University laboratory. Participants: 98 Sprague-Dawley rats. Interventions: Cerebral cortex, skeletal muscle, or visceral fat tissues were exposed in anesthetized animals subjected to either obstructive apneas or intermittent hypoxia (apneic and hypoxic events of 15 s each and 60 events/h) for 1 h. Measurements and Results: Arterial oxyge…

MaleRat modelSettore MED/10 - Malattie Dell'Apparato RespiratorioTissue Oxygenation in Brain Muscle and Fat in Rat Model of ApneaRats Sprague-DawleySleep Apnea SyndromesPhysiology (medical)medicineAnimalsHSP70 Heat-Shock ProteinsHypoxiaMuscle SkeletalCerebral CortexAnalysis of VarianceSleep Apnea Obstructivebusiness.industryVascular Endothelial Growth FactorsApneaSleep apneaIntermittent hypoxiaHypoxia (medical)medicine.diseaseLipid MetabolismGlutathioneTissue oxygenation obstructive apnea intermittent hypoxia animal model oxidative stressRatsOxygenDisease Models Animalmedicine.anatomical_structureTissue oxygenationCerebral cortexAnesthesiaObstructive ApneaNeurology (clinical)Lipid Peroxidationmedicine.symptombusiness
researchProduct

Colonization of adrenal glands and ovaries of mice by HSV-2 variants

1990

HSV-2 strain ER was shown to consist of variants with different pathogenic phenotype: Variant ER+ replicates to high titers in the adrenal glands and the ovaries but much less in the spleen; the testes were not colonized. ER+ migrates to the spinal ganglia and is highly neuroinvasive after i.p. inoculation. Variant ER- replicates 100-1,000 fold less in the adrenal glands and the ovaries, but proceeds to the spinal ganglia without invading the CNS. However, both variants are highly neuropathogenic after direct i.c. injection. We conclude that neuropathogenicity, neuroinvasiveness and the ability to replicate in the adrenal glands as well as ovaries are each determined by different sets of ge…

MaleRatónmedicine.medical_treatmentSpleenOvaryBiologyVirus ReplicationLethal Dose 50MiceSpecies SpecificityVirologyAdrenal GlandsmedicineAnimalsHumansSimplexvirusPropionibacterium acnesVero CellsCells CulturedMice Inbred BALB CAdrenalectomyOvaryAdrenalectomyHerpes SimplexEmbryoGeneral MedicineSilicon DioxideVirologyPhenotypemedicine.anatomical_structureViral replicationVero cellFemaleSpleenArchives of Virology
researchProduct

Replacement therapy for bleeding episodes in factor VII deficiency: A prospective evaluation

2013

Patients with inherited factor VII (FVII) deficiency display different clinical phenotypes requiring ad hoc management. This study evaluated treatments for spontaneous and traumatic bleeding using data from the Seven Treatment Evaluation Registry (STER). One-hundred one bleeds were analysed in 75 patients (41 females; FVII coagulant activity <1-20%). Bleeds were grouped as haemarthroses (n=30), muscle/subcutaneous haematomas (n=16), epistaxis (n=12), gum bleeding (n=13), menorrhagia (n=16), central nervous system (CNS; n=9), gastrointestinal (GI; n=2) and other (n=3). Of 93 evaluable episodes, 76 were treated with recombinant, activated FVII (rFVIIa), eight with fresh frozen plasma (FFP), s…

MaleRegistrieTime FactorsFactor VII Deficiency030204 cardiovascular system & hematologyReplacement therapyProspective evaluationchemistry.chemical_compound0302 clinical medicineMedicineProspective StudiesRegistriesYoung adultProspective cohort studyFactor VII deficiencyChildHematologyFactor VIIHematologyMiddle AgedRecombinant ProteinBlood Coagulation FactorsRecombinant ProteinsTreatment OutcomeCoagulantChild PreschoolFemaleBlood Coagulation FactorHumanAdultmedicine.medical_specialtyAdolescentTime FactorHemorrhageBlood Component TransfusionFactor VIIaBleeds; Factor VII deficiency; Replacement therapy; Adolescent; Adult; Aged; Blood Coagulation Factors; Child; Child Preschool; Coagulants; Drug Administration Schedule; Factor VII Deficiency; Factor VIIa; Female; Hemorrhage; Humans; Infant; Infant Newborn; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Registries; Time Factors; Treatment Outcome; Young Adult; Blood Component Transfusion; HematologyDrug Administration Schedule03 medical and health sciencesYoung AdultInternal medicineHumansAgedBleeding episodesbusiness.industryCoagulantsInfant NewbornInfantSurgeryProspective StudieTreatment evaluationchemistryBleedbusiness030215 immunology
researchProduct

Efficacy of a mandibular advancement intraoral appliance (MOA) for the treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients : a…

2018

Background To evaluate the treatment efficacy of a mandibular advancement intraoral appliance (MOA) for treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients. Material and Methods Eighteen patients (mean=8.39 years old, women=44.4%) were selected. Sleep disorders, sleep bruxism, and temporomandibular disorders were assessed by the Sleep Disturbance Scale for Children (SDSC), the BiteStrip® (portable SB device), and the Research Diagnostic Criteria for Temporomandibular Disorders, respectively. The clinical diagnosis of OSAS was confirmed with a type 3 portable monitor device (ApneaLinkTM Plus). A silicon-based material MOA was used by patients for 60 days, and the resul…

MaleResearch Diagnostic CriteriaSleep BruxismPilot ProjectsArousal03 medical and health sciences0302 clinical medicineHumansMedicineChildGeneral DentistrySleep Apnea ObstructiveSleep disorderOral Medicine and Pathologybusiness.industryHyperhidrosisResearchSleep apnea030206 dentistryTemporomandibular Joint Disorders:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseSleep in non-human animalsObstructive sleep apneaTreatment OutcomeOtorhinolaryngologyChild PreschoolAnesthesiaUNESCO::CIENCIAS MÉDICASFemaleSurgerymedicine.symptomSleep BruxismbusinessMandibular Advancement030217 neurology & neurosurgery
researchProduct

Comparative Effect of Beclomethasone Dipropionate and Cetirizine on Acoustic Rhinometry Parameters in Children With Perennial Allergic Rhinitis: A Ra…

2018

Background and objectives The effect of intranasal corticosteroids and oral antihistamines on acoustic rhinometry parameters has not been directly compared. The primary objective was to compare the effect of a 21-day course of treatment with nasal beclomethasone dipropionate (nBDP) with that of cetirizine (CTZ) on nasal patency measured using acoustic rhinometry in children with perennial allergic rhinitis (PAR). The secondary objective was to compare the effect of both drugs on nasal cytology, symptom severity, sleep quality, and quality of life. Methods In this 21-day, open-label, randomized controlled study, 34 children with PAR (age 6-14 years) with a Total 5-Symptom Score (T5SS) ≥5 rec…

MaleRhinometry Acousticmedicine.medical_specialtyRhinitis Allergic PerennialAdolescentNasal patencyNostrilImmunologyAnti-Inflammatory AgentsGastroenterologyAllergic rhinitislaw.inventionPittsburgh Sleep Quality Index03 medical and health sciences0302 clinical medicineAcoustic rhinometryRandomized controlled trialQuality of lifelawInternal medicineSurveys and QuestionnairesAllergic rhinitimedicineImmunology and AllergyHumans030212 general & internal medicineChildBeneficial effectsChildrenAdministration Intranasalbusiness.industryBeclomethasoneCetirizineCetirizineBeclomethasone dipropionatemedicine.anatomical_structureQuality of LifeNasal administrationFemaleAcoustic rhinometrybusiness030217 neurology & neurosurgerymedicine.drugJournal of investigational allergologyclinical immunology
researchProduct

Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk

2008

The obstructive sleep apnea syndrome (OSAS) is characterized by collapse of the upper airway during sleep, recurring apneas, intermittent hypoxemia and daytime somnolence. OSAS is often associated with obesity, and its prevalence is expected to rise due to the obesity epidemics worldwide. OSAS is associated with increased cardiovascular risk which appears to be normalized by treatment with nasal continuous positive airway pressure (nCPAP) during sleep, suggesting an independent role of OSAS in accelerating atherosclerosis. Insulin resistance (IR) and the metabolic syndrome (MetS) are often found in OSAS patients, but the relative role played by OSAS and obesity is still unclear. Both OSAS a…

MaleRiskmedicine.medical_specialtySympathetic nervous systemPhysiologymedicine.medical_treatmentSettore MED/10 - Malattie Dell'Apparato RespiratorioGlucose metabolism dyslipidemia sleep loss animal models children adipocyteHypoxemiaInsulin resistancestomatognathic systemPhysiology (medical)Internal medicineAdipocytesmedicineAnimalsHumansObesityContinuous positive airway pressureChildInflammationSleep Apnea Obstructivebusiness.industryGeneral Medicinemedicine.diseaseObesitynervous system diseasesrespiratory tract diseasesObstructive sleep apneaDisease Models AnimalGlucosemedicine.anatomical_structureEndocrinologyAdipose TissueCardiovascular DiseasesCardiologyMetabolic syndromemedicine.symptombusinessDyslipidemiaArchives of Physiology and Biochemistry
researchProduct

Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study

2017

AbstractPatients with intermediate-risk pulmonary embolism (PE) may, depending on the method and cut-off values used for definition, account for up to 60% of all patients with PE and have an 8% or higher risk of short-term adverse outcome. Although four non-vitamin K-dependent direct oral anticoagulants (NOACs) have been approved for the treatment of venous thromboembolism, their safety and efficacy as well as the optimal anticoagulation regimen using these drugs have not been systematically investigated in intermediate-risk PE. Moreover, it remains unknown how many patients with intermediate-high-risk and intermediate-low-risk PE were included in most of the phase III NOAC trials. The ongo…

MaleRiskmedicine.medical_specialtypulmonary embolismDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentHemorrhageintermediate risk030204 cardiovascular system & hematologyDabigatran03 medical and health sciencesYoung Adult0302 clinical medicineRecurrenceInternal medicineGermanymedicineHumansdabigatran030212 general & internal medicineProspective StudiesProspective cohort studySurvival analysisvenous thromboembolism recurrencebusiness.industryHeparinAnticoagulantsHematologyThrombolysisHeparinReference Standardsmedicine.diseaseThrombosisSurvival Analysis3. Good healthPulmonary embolismright ventricular functionRegimenTreatment OutcomeResearch Designmajor bleedingAcute Diseasedabigatran; intermediate risk; major bleeding; pulmonary embolism; right ventricular function; venous thromboembolism recurrenceFemalebusinessmedicine.drugFollow-Up Studies
researchProduct

Interruption of Macrophage-Derived IL-27(p28) Production by IL-10 during Sepsis Requires STAT3 but Not SOCS3

2014

Abstract Severe sepsis and septic shock are leading causes of morbidity and mortality worldwide. Infection-associated inflammation promotes the development and progression of adverse outcomes in sepsis. The effects of heterodimeric IL-27 (p28/EBI3) have been implicated in the natural course of sepsis, whereas the molecular mechanisms underlying the regulation of gene expression and release of IL-27 in sepsis are poorly understood. We studied the events regulating the p28 subunit of IL-27 in endotoxic shock and polymicrobial sepsis following cecal ligation and puncture. Neutralizing Abs to IL-27(p28) improved survival rates, restricted cytokine release, and reduced bacterial burden in C57BL/…

MaleSTAT3 Transcription Factormedicine.medical_treatmentImmunologySuppressor of Cytokine Signaling ProteinsInflammationSpleenBiologyArticleSepsisMiceSepsismedicineAnimalsHumansImmunology and AllergyReceptors CytokineAntibodies BlockingCecumCells CulturedMice KnockoutSeptic shockInterleukinsMacrophagesReceptors Interleukinmedicine.diseaseBacterial LoadInterleukin-10Mice Inbred C57BLToll-Like Receptor 4Adaptor Proteins Vesicular TransportDisease Models AnimalOxidative StressInterleukin 10Cytokinemedicine.anatomical_structureIntegrin alpha MSuppressor of Cytokine Signaling 3 ProteinMyeloid Differentiation Factor 88ImmunologyTLR4biology.proteinmedicine.symptomJournal of Immunology
researchProduct

Does Sleep Mediate the Association between School Pressure, Physical Activity, Screen Time, and Psychological Symptoms in Early Adolescents? A 12-Cou…

2019

This study examines the mediating role of sleep duration and sleep onset difficulties in the association of school pressure, physical activity, and screen time with psychological symptoms in early adolescents. Data were retrieved from 49,403 children (13.7 &plusmn

MaleSTRESSHealth Toxicology and MutagenesisPsychological interventionSocial Scienceslcsh:MedicinePoison controlCHILDRENSuicide prevention0302 clinical medicinenuoretmielenterveysSleep Initiation and Maintenance DisordersAcademic PerformanceMedicine and Health SciencesPrevalence030212 general & internal medicineadolescentsChildEUROPEAN ADOLESCENTSSchoolsAGE-OF-ONSETta3142EuropeDEPRESSIVE SYMPTOMSFemalemedicine.symptomSleep onsetBEHAVIORmental healthClinical psychologyAdolescentDISORDERSEXERCISEIrritabilityArticleuni (lepotila)Screen Time03 medical and health sciencesScreen timeSciences socialesInjury preventionmedicineHumansVALIDITYsleepExerciseMETAANALYSISbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthMental healthSciences humainesmental health adolescents sleep AGE-OF-ONSET EUROPEAN ADOLESCENTS DEPRESSIVE SYMPTOMS CHILDREN STRESS METAANALYSIS DISORDERS EXERCISE VALIDITY BEHAVIORSelf Reportbusiness030217 neurology & neurosurgeryStress Psychological
researchProduct

Sleep duration and sarcopenia in adults aged ≥ 65 years from low and middle-income countries

2022

Background: Sleep duration may influence risk for sarcopenia but studies on this topic are scarce, especially from low and- middle-income countries (LMICs). Thus, the aim of the present study was to investigate the association between sleep duration and sarcopenia among adults aged ≥ 65 years from five LMICs (China, Ghana, India, Russia, South Africa). Methods: Cross-sectional, community-based data from the WHO study on global ageing and adult health (SAGE) were analysed. Sarcopenia was defined as having low skeletal muscle mass (SMM) and weak handgrip strength, while severe sarcopenia was defined as having low SMM, weak handgrip strength, and slow gait speed. Self-reported sleep duration i…

MaleSarcopeniaAgingCross-Sectional StudiesSleep problems · Sarcopenia · Low- and- middle income countries · Older adultsHand StrengthSmith L. Shin J. I. Veronese N. Soysal P. López Sánchez G. F. Pizzol D. Demurtas J. Tully M. A. Barnett Y. Butler L. et al. -Sleep duration and sarcopenia in adults aged ≥ 65 years from low and middle-income countries.- Aging clinical and experimental research 2022PrevalenceHumansFemaleGeriatrics and GerontologySleepDeveloping CountriesAging Clinical and Experimental Research
researchProduct